PLUR
Pluri, Inc.
NASDAQ · Healthcare · Biotechnology · IL
$0.85
−8.58%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.47x
- Price / sales
- 10.55x
- Price / cash flow
- -0.55x
Enterprise value
- Enterprise value
- $43.4M
- EV / sales
- 42.75x
- EV / EBITDA
- -1.81x
- EV / EBIT
- -1.74x
- Market cap
- $10.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026